FGen is a Swiss contract research organization specialized in synthetic biology and high throughput analysis of cells. FGen has commercialized the nanoliter-reactor screening platform which enables the phenotypic high throughput analysis of large number of cells. The technology is based on encapsulation of cells in hydrogel beads, which allows to analyze 3D cell cultures, such as spheroids, and the characterization with respect to secreted products. For example, the nanoliter-reactor platform represents a powerful tool for screening of antibody producing cells in discovery as well as in cell line development, or for the identification and analysis of cancer spheroids in mixed cell populations.
We would be happy to learn how we can support you in the analysis of large numbers of cells with an unique and powerful technology platform.